FDA Outsourcing Facility Fee Rates: Fiscal Year 2016

August 7, 2015

Under the FD&C Act, FDA is authorized to collect annual establishment and reinspection fees from human drug compounding outsourcing facilities. These fees are collected on an annual basis, and include an establishment fee from outsourcing facilities that have elected to register, as well as a reinspection fee for each reinspection of an outsourcing facility.

FDA updates these fees on a yearly basis, and they are effective for the fiscal year (October 1 to September 30). In addition, the Agency offers a steeply discounted price for qualified small businesses. The Weinberg Group can help determine if you qualify for this discounted price.

The rates for fiscal year 2016 are as follows:

Qualified Small Business Establishment Fee

$5,203

Non-Small Business Establishment Fee

$16,456

Reinspection Fee

$15,610

 

We are qualified and have helped many facilities with the FDA registration process in the past. To learn more about how we can help your facility register and reduce the total cost to to do so, please contact us.




Agency Alerts

August 7, 2015

FDA Outsourcing Facility User Fee Rates: Fiscal Year 2019

According to a recently released notice from the FDA, “the FD&C Act authorizes FDA to assess and collect an annual establishment fee from outsourcing facilities, as well as a re-inspection fee for...

Read More
Agency Alerts

August 7, 2015

FDA Biosimilar User Fee Rates: Fiscal Year 2016

In order to expedite the review process of biosimilar biological products, FDA is authorized to assess and collect fees from sponsors. The fees are collected for various activities related to...

Read More
Agency Alerts General Regulatory

August 7, 2015

FDA Outsourcing Facility Fee Rate: Fiscal Year 2017

According to section 503B(d)(4) of the Federal Food, Drug, and Cosmetic (FD&C) an outsourcing facility is “a facility at one geographic location or address that is engaged in the compounding of...

Read More